Biosafety evaluation of recombinant live oral bacterial vaccines in the context of European regulation

This publication has 22 references indexed in Scilit:

• Biosafety aspects of the recombinant live oral Vibrio cholerae vaccine strain CVD 103-HgR
  Vaccine, 2004
• Two Studies Evaluating the Safety and Immunogenicity of a Live, Attenuated Shigella flexneri 2a Vaccine (SC602) and Excretion of Vaccine Organisms in North American Volunteers
  Infection and Immunity, 2004
• Biological containment of genetically modified Lactococcus lactis for intestinal delivery of human interleukin 10
  Nature Biotechnology, 2003
• Peru-15, an Improved Live Attenuated Oral Vaccine Candidate for Vibrio cholerae O1
  The Journal of Infectious Diseases, 1995
• The live oral typhoid vaccine Ty21a is arpoSmutant and is susceptible to various environmental stresses
  FEMS Microbiology Letters, 1995
• Effects of Genetically Engineered Microorganisms on Microbial Populations and Processes in Natural Habitats
  Published by Elsevier ,1995
• SUICIDAL GENETIC ELEMENTS AND THEIR USE IN BIOLOGICAL CONTAINMENT OF BACTERIA
  Annual Review of Microbiology, 1993
• The mucosal immune system: from fundamental concepts to vaccine development
  Vaccine, 1992
• SAFETY, IMMUNOGENICITY, AND EFFICACY OF RECOMBINANT LIVE ORAL CHOLERA VACCINES, CVD 103 AND CVD 103-HgR
  The Lancet, 1988
• Isolation and Characterization of Gal E Mutant Ty 21a of Salmonella typhi: A Candidate Strain for a Live, Oral Typhoid Vaccine
  The Journal of Infectious Diseases, 1975